Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

Use finasteride, dutasteride, and minoxidil for hair loss treatment.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Minoxidil applied before and after surgery improves skin flap survival in rats.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

Case reports are important in medical science for discovering drugs and identifying rare conditions, despite their limitations.

Photobiomodulation helps reduce pain, lessen inflammation, heal wounds, and can be used in skin treatments. It also boosts hair growth in women with hair loss and may help fight microbes and prevent respiratory issues in COVID-19.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

PHAT may improve hair growth better than PRP alone.

More research is needed to understand hair and scalp disorders in people with skin of color.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

The document concludes that molluscum contagiosum is a common, benign skin infection in children, often healing without scarring.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Menopause affects hair and skin; more research needed for treatment.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

Adding de-epithelialization to the follicular isolation technique improves hair transplant results for eyebrows and eyelashes.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.